Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Copyright © 2017 by the National Comprehensive Cancer Network.
MeSH terms
-
Antiemetics / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzodiazepines / therapeutic use
-
Granisetron / therapeutic use
-
Humans
-
Neoplasms / complications
-
Neoplasms / therapy
-
Olanzapine
-
Serotonin Antagonists / therapeutic use
-
Vomiting / drug therapy*
-
Vomiting / etiology
-
Vomiting / prevention & control
Substances
-
Antiemetics
-
Antineoplastic Agents
-
Serotonin Antagonists
-
Benzodiazepines
-
Olanzapine
-
Granisetron